Trials / Completed
CompletedNCT00348504
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,300 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to compare the efficacy of levosimendan and dobutamine on all-cause mortality in the 180 days following randomization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levosimendan | |
| DRUG | dobutamine |
Timeline
- Start date
- 2003-03-01
- Completion
- 2005-06-01
- First posted
- 2006-07-04
- Last updated
- 2007-11-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00348504. Inclusion in this directory is not an endorsement.